The store will not work correctly when cookies are disabled.
4-(piperidin-1-yl)-7H-pyrido[4,3,2-de][1,7]phenanthrolin-7-one
ID: ALA3347506
PubChem CID: 10403477
Max Phase: Preclinical
Molecular Formula: C19H16N4O
Molecular Weight: 316.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ncccc2-c2nccc3c(N4CCCCC4)cnc1c23
Standard InChI: InChI=1S/C19H16N4O/c24-19-17-13(5-4-7-20-17)16-15-12(6-8-21-16)14(11-22-18(15)19)23-9-2-1-3-10-23/h4-8,11H,1-3,9-10H2
Standard InChI Key: WRGYMSQAWROLSQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 28 0 0 0 0 0 0 0 0999 V2000
8.3546 -22.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3534 -23.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0673 -23.4768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0655 -21.8259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7800 -22.2345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7787 -23.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4908 -23.4744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2081 -23.0603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9195 -23.4719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6330 -23.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6308 -22.2338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4931 -21.8195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2088 -22.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9267 -21.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4949 -20.9951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4902 -24.2983 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2100 -20.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9269 -20.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3438 -21.8208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0536 -22.2347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7644 -21.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7674 -21.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0535 -20.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3364 -20.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 12 1 0
6 7 1 0
7 8 1 0
13 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 14 2 0
12 13 1 0
13 14 1 0
14 18 1 0
17 15 1 0
15 12 2 0
7 16 2 0
17 18 2 0
11 19 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.36 | Molecular Weight (Monoisotopic): 316.1324 | AlogP: 3.23 | #Rotatable Bonds: 1 |
Polar Surface Area: 58.98 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.54 | CX LogP: 2.56 | CX LogD: 2.56 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.54 | Np Likeness Score: 0.01 |
References
1. Chen JL, Sperry J, Ip NY, Brimble MA. (2011) Natural products targeting telomere maintenance, 2 (4): [10.1039/C0MD00241K] |